Previewing ASCO 2024: A Sneak Peek Into ARC-9, ESOPEC

Zev Wainberg, MD, MSc, of University of California, Los Angeles, and Nataliya Uboha, MD, PhD, of University of Wisconsin School of Medicine and Public Health, highlight the innovative ARC-9 study on rechallenging FOLFOX chemotherapy in colorectal cancer, as well as other exciting developments set to occur at the 2024 ASCO Annual Meeting.

Advertisement
Advertisement
Advertisement

DocWire Content Partners

Powered by DocWire News

The Latest From GI Oncology Now

The Latest From Heme Today

Expert Interviews

Network Websites